EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

OPG and BAFF as predictive biomarkers of the severity of SARS ‐ CoV ‐2 infection

Andy Ruiz, Carlos Peña-Bates, Lucero A Ramon-Luing, Daniel Baca-Nuñez, Marco Antonio Vargas, Karen Medina-Quero, Neptali Gutierrez, Joel A Vázquez-Pérez, Ramcés Falfán-Valencia, Gloria Pérez-Rubio, Carolina Di Benedetto, Ivette Buendia-Roldan und 3 weitere

Journal of Cellular and Molecular Medicine · 2025-02 · 29 (3)

DOI: 10.1111/jcmm.70189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 31.01.2025. Verfasst von Andy Ruiz und 14 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico. Hauptthemen laut MEDLINE: COVID-19, B-Cell Activating Factor, Osteoprotegerin. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: COVID Catalyst Award Henry Wheeler Center, Ministry of Health of Mexico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Molecules of the tumour necrosis factor superfamily (TNFSF) are key players in immune regulation; an increase in some TNFSF molecules has been reported during severe COVID‐19. In this study, we profiled and evaluated TNFSF members in the serum of COVID‐19 vaccine‐naïve patients to identify potential biomarkers associated with disease severity. Our data show that TRAIL serum levels are lower in severely affected patients than those mildly affected by COVID‐19 (AUC 0.8, p = 0.0003). On the contrary, OPG and BAFF serum levels are higher in severe COVID‐19 compared to mild COVID‐19 cases (AUC 0.8, p = 0.0001; AUC 0.7, p = 0.0012; respectively) and moderate COVID‐19 cases (OPG p < 0.01), BAFF ( p < 0.05). At the transcriptional level, TRAIL, OPG and BAFF are elevated in severe compared to mild COVID‐19 cases, with OPG and BAFF also higher in moderate compared to mild COVID‐19 patients. Additionally, we found that APRIL, LIGHT, CD30L and CD40L protein‐levels are higher in COVID‐19 patients compared to healthy donors but not significantly different between various COVID‐19 clinical statuses. Finally, we found that TNF‐α, TNF‐β, RANKL and TWEAK protein levels were not affected during COVID‐19. Our work identifies OPG and BAFF as potential biomarkers and therapeutic targets for preventing severe COVID‐19. Due to the opposite contradictory levels of TRAIL (protein/transcriptional level), its role during COVID‐19 should be elucidated and clarified with more in‐depth studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19B-Cell Activating FactorOsteoprotegerinHumansBiomarkersFemaleMaleSARS-CoV-2Middle AgedSeverity of Illness IndexTNF-Related Apoptosis-Inducing LigandAdultAged

Stichwörter der Autor:innen

BAFFCOVID‐19OPGTRAILseverity

Substanzen

B-Cell Activating FactorBiomarkersOsteoprotegerinTNFSF13B protein, humanTNF-Related Apoptosis-Inducing LigandTNFSF10 protein, human

Autor:innen und Institutionen

  • Research Unit, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
  • Research Unit, Escuela Militar de Graduados de Sanidad, Mexico City, Mexico.
  • Department of Radiation Oncology, University of California, San Francisco, California, USA.

ORCID-Profile: Leslie Chavez-Galan

Förderung

  • COVID Catalyst Award Henry Wheeler Center
  • Ministry of Health of Mexico

Zitieren

APA

Ruiz, A., Peña-Bates, C., Ramon-Luing, L. A., Baca-Nuñez, D., Vargas, M. A., Medina-Quero, K., Gutierrez, N., Vázquez-Pérez, J. A., Falfán-Valencia, R., Pérez-Rubio, G., Di Benedetto, C., Buendia-Roldan, I., Selman, M., Betancur, P., & Chavez-Galan, L. (2025). OPG and BAFF as predictive biomarkers of the severity of SARS ‐ CoV ‐2 infection. Journal of Cellular and Molecular Medicine, 29(3). https://doi.org/10.1111/jcmm.70189

Vancouver

Ruiz A, Peña-Bates C, Ramon-Luing LA, Baca-Nuñez D, Vargas MA, Medina-Quero K, et al. OPG and BAFF as predictive biomarkers of the severity of SARS ‐ CoV ‐2 infection. Journal of Cellular and Molecular Medicine. 2025;29(3). doi:10.1111/jcmm.70189

BibTeX
@article{Ruiz2025,
  author = {Ruiz, Andy and Peña-Bates, Carlos and Ramon-Luing, Lucero A and Baca-Nuñez, Daniel and Vargas, Marco Antonio and Medina-Quero, Karen and Gutierrez, Neptali and Vázquez-Pérez, Joel A and Falfán-Valencia, Ramcés and Pérez-Rubio, Gloria and Di Benedetto, Carolina and Buendia-Roldan, Ivette and Selman, Moisés and Betancur, Paola and Chavez-Galan, Leslie},
  title = {OPG and BAFF as predictive biomarkers of the severity of SARS ‐ CoV ‐2 infection},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  volume = {29},
  number = {3},
  doi = {10.1111/jcmm.70189}
}
Kostenlos starten →